Free shipping on all orders over $ 500

TAK-632

Cat. No. M2235

All AbMole products are for research use only, cannot be used for human consumption.

TAK-632 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 35 In stock
10mg USD 50 In stock
25mg USD 86 In stock
50mg USD 140 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TAK-632 is a selective kinase inhibitor targeting pan-RAF inhibition. TAK-632 inhibited phosphorylation of MEK (pMEK) in melanoma A375 cells (BRAFV600E) with an IC50 value of 12 nM. TAK-632 suppresses RAF activity in BRAF wild-type cells with minimal RAF paradoxical activation. TAK-632 induces RAF dimerization but inhibits the kinase activity of the RAF dimer, probably because of its slow dissociation from RAF. TAK-632 demonstrates potent antiproliferative effects both on NRAS-mutated melanoma cells and BRAF-mutated melanoma cells with acquired resistance to BRAF inhibitors through NRAS mutation or BRAF truncation.

Customer Product Validations & Biological Datas
Source Cancer Res (2013). Figure 1. TAK-632
Method Western blot analysis
Cell Lines A431, CsFb, and HeLa cells
Concentrations 0-5000 nmol/L
Incubation Time 2 h
Results MEK and ERK phosphorylation was modestly induced at low TAK-632 concentrations but inhibited at higher concentrations in BRAF wild-type cells
Chemical Information
Molecular Weight 554.52
Formula C27H18F4N4O3S
CAS Number 1228591-30-7
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Hao Zhang, et al. N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[ d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure-Act䲧畸Ỵ畹㧀畷羹皖睑ꏰऒŤऒĀ

[2] Xiaofei Chen, et al. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3

[3] Xiaokai Li, et al. Design and synthesis of N-(4-aminopyridin-2-yl)amides as B-Raf(V600E) inhibitors

[4] Akito Nakamura, et al. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma

[5] Masanori Okaniwa, et al. Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives

Related Raf Products
GDC-0879

GDC-0879 is a potent and selective B-Raf kinase inhibitor with an EC50 of 0.75 µM.

Vemurafenib (PLX4032)

Vemurafenib (PLX4032) is a first-in-class, potent, selective inhibitor of B-Raf that inhibits RAFV600E and C-RAF-1 activity with IC50s of 31 nM and 48 nM, respectively.In addition, Vemurafenib induces autophagy.

PLX-4720

PLX-4720 is a selective BRAFV600E inhibitor with the IC50 values of 160 nM and 130 nM for B-Raf and BRK respectively.

SB590885

SB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.

ZM 336372

ZM 336372 is a potent, selective ATP-competitive inhibitor of c-Raf in vitro (IC50 = 70 nM for inhibition of human c-Raf).

  Catalog
Abmole Inhibitor Catalog




Keywords: TAK-632 supplier, Raf, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.